Insider Transactions in Q1 2022 at Boston Scientific Corp (BSX)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 29
2022
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Open market or private sale
|
Direct |
10,269
-25.33%
|
$462,105
$45.0 P/Share
|
|
Mar 29
2022
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
5,411
+11.77%
|
$86,576
$16.31 P/Share
|
|
Mar 28
2022
|
Ian T Meredith EVP Global Chief Med Officer |
SELL
Open market or private sale
|
Direct |
6,588
-19.0%
|
$283,284
$43.68 P/Share
|
|
Mar 22
2022
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
11,236
-7.9%
|
$494,384
$44.5 P/Share
|
|
Mar 15
2022
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
7,500
-4.62%
|
$315,000
$42.34 P/Share
|
|
Mar 03
2022
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
1,779
-0.81%
|
$76,497
$43.96 P/Share
|
|
Mar 03
2022
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
3,603
+1.61%
|
-
|
|
Mar 02
2022
|
Daniel J. Brennan EVP and CFO |
SELL
Open market or private sale
|
Direct |
11,029
-4.01%
|
$485,276
$44.03 P/Share
|
|
Mar 01
2022
|
David A Pierce EVP Pres MedSurg |
SELL
Open market or private sale
|
Direct |
1,726
-100.0%
|
$74,218
$43.94 P/Share
|
|
Feb 28
2022
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
640
-1.79%
|
$28,160
$44.17 P/Share
|
|
Feb 28
2022
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
1,528
+4.1%
|
-
|
|
Feb 28
2022
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,988
-0.72%
|
$87,472
$44.17 P/Share
|
|
Feb 28
2022
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,481
+1.59%
|
-
|
|
Feb 28
2022
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
479
-0.29%
|
$21,076
$44.17 P/Share
|
|
Feb 28
2022
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
1,630
+0.99%
|
-
|
|
Feb 28
2022
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
300
-0.91%
|
$13,200
$44.17 P/Share
|
|
Feb 28
2022
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
1,019
+2.99%
|
-
|
|
Feb 28
2022
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
419
-1.58%
|
$18,436
$44.17 P/Share
|
|
Feb 28
2022
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
1,426
+5.11%
|
-
|
|
Feb 28
2022
|
Edward F Mackey EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,084
-2.01%
|
$47,696
$44.17 P/Share
|
|
Feb 28
2022
|
Edward F Mackey EVP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
2,444
+4.33%
|
-
|
|
Feb 28
2022
|
Ian T Meredith EVP Global Chief Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
300
-0.86%
|
$13,200
$44.17 P/Share
|
|
Feb 28
2022
|
Ian T Meredith EVP Global Chief Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,019
+2.83%
|
-
|
|
Feb 28
2022
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,130
-0.38%
|
$357,720
$44.17 P/Share
|
|
Feb 28
2022
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,330
+0.85%
|
-
|
|
Feb 28
2022
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
624
-0.44%
|
$27,456
$44.17 P/Share
|
|
Feb 28
2022
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
2,037
+1.41%
|
-
|
|
Feb 28
2022
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
238
-0.75%
|
$10,472
$44.17 P/Share
|
|
Feb 28
2022
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
815
+2.52%
|
-
|
|
Feb 28
2022
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
SELL
Payment of exercise price or tax liability
|
Direct |
564
-0.32%
|
$24,816
$44.17 P/Share
|
|
Feb 28
2022
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
BUY
Exercise of conversion of derivative security
|
Direct |
1,630
+0.91%
|
-
|
|
Feb 28
2022
|
Scott Olson SVP & Pres, CRM, Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
766
-4.79%
|
$33,704
$44.17 P/Share
|
|
Feb 28
2022
|
Scott Olson SVP & Pres, CRM, Diagnostics |
BUY
Exercise of conversion of derivative security
|
Direct |
1,426
+8.19%
|
-
|
|
Feb 28
2022
|
David A Pierce EVP Pres MedSurg |
SELL
Payment of exercise price or tax liability
|
Direct |
718
-29.38%
|
$31,592
$44.17 P/Share
|
|
Feb 28
2022
|
David A Pierce EVP Pres MedSurg |
BUY
Exercise of conversion of derivative security
|
Direct |
2,444
+50.0%
|
-
|
|
Feb 28
2022
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
SELL
Payment of exercise price or tax liability
|
Direct |
300
-1.29%
|
$13,200
$44.17 P/Share
|
|
Feb 28
2022
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
BUY
Exercise of conversion of derivative security
|
Direct |
1,019
+4.19%
|
-
|
|
Feb 28
2022
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
374
-1.0%
|
$16,456
$44.17 P/Share
|
|
Feb 28
2022
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,222
+3.16%
|
-
|
|
Feb 28
2022
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
1,031
-1.09%
|
$45,364
$44.17 P/Share
|
|
Feb 28
2022
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
1,833
+1.91%
|
-
|
|
Feb 23
2022
|
Wendy Carruthers EVP, Human Resources |
SELL
Bona fide gift
|
Direct |
2,300
-1.41%
|
-
|
|
Feb 23
2022
|
David A Pierce EVP Pres MedSurg |
SELL
Open market or private sale
|
Direct |
1,761
-100.0%
|
$75,723
$43.28 P/Share
|
|
Feb 22
2022
|
Daniel J. Brennan EVP and CFO |
SELL
Open market or private sale
|
Direct |
53,182
-16.31%
|
$2,233,644
$42.75 P/Share
|
|
Feb 22
2022
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
53,182
+4.15%
|
$691,366
$13.51 P/Share
|
|
Feb 22
2022
|
David A Pierce EVP Pres MedSurg |
SELL
Open market or private sale
|
Direct |
1,884
-51.69%
|
$79,128
$42.55 P/Share
|
|
Feb 21
2022
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,624
-0.59%
|
$68,208
$42.55 P/Share
|
|
Feb 21
2022
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,661
+1.32%
|
-
|
|
Feb 21
2022
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
230
-0.71%
|
$9,660
$42.55 P/Share
|
|
Feb 21
2022
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
779
+2.36%
|
-
|